Nithin Karakala1, Karthik Raghunathan, Andrew D Shaw. 1. aDivision of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina bDepartment of Anesthesiology, Duke University Medical Center, Durham VAMC, Durham, North Carolina, USA.
Abstract
PURPOSE OF REVIEW: Septic shock is one of the most common and life-threatening conditions afflicting critically ill patients. Intravenous volume resuscitation is considered an initial and very important step in management. The most suitable fluid for volume expansion during septic shock remains unclear. In this review, we focus on the benefits and adverse effects of the most commonly used intravenous fluids in critically ill septic patients. RECENT FINDINGS: The debate about the benefits of colloids over crystalloids has been ongoing for the last few decades. With recent literature showing apparent harm from the use of hydroxyethyl starches (HESs), and given the growing concerns of adverse renal and acid-base abnormalities associated with 0.9% saline compared with balanced crystalloid solutions, it may be time to change the nature of the 'fluid debate'. SUMMARY: Crystalloids should still be considered as the first-choice drug for volume resuscitation in patients with septic shock. Colloids such as albumin can be considered in some clinical settings. HES should be avoided. Balanced crystalloids might have an important role to play in the management of septic shock.
PURPOSE OF REVIEW: Septic shock is one of the most common and life-threatening conditions afflicting critically ill patients. Intravenous volume resuscitation is considered an initial and very important step in management. The most suitable fluid for volume expansion during septic shock remains unclear. In this review, we focus on the benefits and adverse effects of the most commonly used intravenous fluids in critically ill septicpatients. RECENT FINDINGS: The debate about the benefits of colloids over crystalloids has been ongoing for the last few decades. With recent literature showing apparent harm from the use of hydroxyethyl starches (HESs), and given the growing concerns of adverse renal and acid-base abnormalities associated with 0.9% saline compared with balanced crystalloid solutions, it may be time to change the nature of the 'fluid debate'. SUMMARY: Crystalloids should still be considered as the first-choice drug for volume resuscitation in patients with septic shock. Colloids such as albumin can be considered in some clinical settings. HES should be avoided. Balanced crystalloids might have an important role to play in the management of septic shock.
Authors: Scott L Weiss; Luke Keele; Fran Balamuth; Neika Vendetti; Rachael Ross; Julie C Fitzgerald; Jeffrey S Gerber Journal: J Pediatr Date: 2017-01-04 Impact factor: 4.406
Authors: Fran Balamuth; Marlena Kittick; Peter McBride; Ashley L Woodford; Nicole Vestal; T Charles Casper; Melissa Metheney; Katherine Smith; Natalie J Atkin; Jill M Baren; J Michael Dean; Nathan Kuppermann; Scott L Weiss Journal: Acad Emerg Med Date: 2019-07-18 Impact factor: 3.451
Authors: Scott L Weiss; Fran Balamuth; Elliot Long; Graham C Thompson; Katie L Hayes; Hannah Katcoff; Marlena Cook; Elena Tsemberis; Christopher P Hickey; Amanda Williams; Sarah Williamson-Urquhart; Meredith L Borland; Stuart R Dalziel; Ben Gelbart; Stephen B Freedman; Franz E Babl; Jing Huang; Nathan Kuppermann Journal: Trials Date: 2021-11-06 Impact factor: 2.728